期刊文献+

一个新的PROC基因突变的检出及其致病机制的研究

Detection of a novel mutation in PROC gene and the mutation-related pathogenic mechanism
原文传递
导出
摘要 目的:鉴定一个遗传性蛋白C缺乏症患者的基因突变,并对该突变的致病机制进行研究。方法:采用血液基因组提取试剂盒获取遗传性蛋白C缺乏症患者的DNA,用聚合酶链反应(PCR)法扩增其PROC基因所有外显子及侧翼序列并测序,应用Chromas软件分析并检出基因突变;将带有突变位点的PROC基因c DNA序列克隆到载体后转染至HEK293细胞,采用定量PCR法检测突变基因m RNA的表达水平。结果:检出一个PROC基因的新突变[c.740G>A(p.Trp247*)],并在细胞水平证明突变基因m RNA的表达水平出现下调。结论 :PROC基因无义突变的m RNA可能通过无义介导的m RNA降解途径快速降解,从而导致遗传性蛋白C缺乏症。 Objective: To identify a novel mutation of PROC gene and study the mutation-related pathogenic mecha- nism in a patient with hereditary protein C deficiency. Methods: DNA sample was obtained from a patient with hereditary protein C deficiency using blood genomic DNA extraction kit. All 9 exons and the flank sequence of PROC gene were am- plified by polymerase chain reaction (PCR) and the sequence was analyzed by Chromas software. Recombinants expressing mutant PROC gene were constructed and transfected into HEK293 cells, and the level of PROC mRNA expression was detected by qPCR. Results: A novel PROC gene mutation p.Trp247* was identified, and down-regulation of mutant PROC gene expression at mRNA level was detected. Conclusions: A nonsense mutation in PROC gene is identified, which caus- es rapid degradation by nonsense-mediated mRNA decay (NMD) pathway, resulting in the occurrence of hereditary protein C deficiency.
出处 《诊断学理论与实践》 2014年第6期584-587,共4页 Journal of Diagnostics Concepts & Practice
基金 国家自然科学基金(31071107)
关键词 遗传性蛋白C缺乏症 蛋白C基因 无义介导的m RNA降解 Hereditary protein C deficiency PROC gene Nonsense-mediated mRNA decay
  • 相关文献

参考文献18

  • 1Ohga S, Ishiguro A, Takahashi Y, et al. Protein C defi- ciency as the major cause of thrombophilias in childhood [J]. Pediatr Int, 2013,55(3):267-271.
  • 2Wypasek E, Undas A. Protein C and protein S deficiency- practical diagnostic issues[J]. Adv Clin Exp Med, 2013,22(4): 459-467.
  • 3Danese S, Vetrano S, Zhang L, et al. The protein C path- way in tissue inflammation and injury: pathogenic role and therapeutic implications[J]. Blood,2010,115 (6): 1121- 1130.
  • 4Pescatore SL. Clinical management of protein C deficien- cy[J]. Expert Opin Pharrnacother,2001,2(3):431-439.
  • 5Lee M J, Kim KM, Kim JS, et al. Long-term survival of a child with homozygous protein C deficiency successfully treated with living donor liver transplantation[J]. Pediatr Transplant,2009,13 (2):251-254.
  • 6Shamsher MK, Chuzhanova NA, Friedman B, et al. Iden- tification of an intronic regulatory element in the human protein C (PROC) gene[J]. Hum Genet,2000,107(5):458- 465.
  • 7Hoshi S, Hijikata M, Togashi Y, et al. Protein C deficien- cy in a family with thromboembolism and identified gene mutations[J]. Intern Med,2007,46(13):997-1003.
  • 8Tormene D, Fortuna S, Tognin G, et al. The incidence ofvenous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study[J]. J Thromb Haemost,2005,3(7): 1414-1420.
  • 9Cooper PC, Hill M, Maclean RM. The phenotypic and genetic assessment of protein C deficiency[J]. Int J Lab Hematol,2012,34(4):336-346.
  • 10Ding Q, Shen W, Ye X, et al. Clinical and genetic fea- tures of protein C deficiency in 23 unrelated Chinese pa- tients[J]. Blood Cells Mol Dis,2013,50(1):53-58.

二级参考文献108

  • 1王细福,张昆南,高幼奇,赖旻瑶,谢旭芳,涂晓云,王文丁.脑梗塞患者血浆蛋白C变化的初步探讨[J].临床神经病学杂志,1993,6(4):220-221. 被引量:2
  • 2王振义.蛋白C系统的研究进展[J].国外医学:输血及血液学分册,1986,9:104-104.
  • 3[1]KLEIN JD,WALKER FJ,Purification of protein C activator from the venom of the southern copperhead snake (Agkistrodon Contortrix)[J].Biochemitry,1986,25 (15):4175-4179.
  • 4[2]KOGAN AE,MAKAROW AN,BOBRUSKIN ID,et al.Comparative study of protein C activators from the agkistrodon snake venoms[J].Thromb Res,1991,62:775.
  • 5[5]GANAPATHYRAMAN L,SHANTHI P,BABA KRISHNAN K,et al.Protein C levels in ischemic heart disease[J].Indian Heart J,1996,48 (2):125-127.
  • 6[6]GENSINI GP,ROSTAGNO C,ABBOTE R,et al.Increased protein C and fibrinopeptide a concentration in patients with angina[J].Thromb Haemost,1984,52 (3):263-266.
  • 7[7]GRANGER CB,MILLER JM,BOVILL EG,et al.Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes[J].Circulation,1995,91:(7) 1929-1935.
  • 8[10]D'ANGELO A,GEROSA S,D'ANGELO SV,et al.Protein S and Protein C anticoagulant activity in acute and chronic cardioc ischemic syndromes-relationship to inflamemation complement activation and in vivo thrombin activity[J].Thromb Res,1994,15(2):133.
  • 9[12]VIGANO S,MANNUCCI P M,ANGELO A D,et al.Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes[J].Thromb Haemost,1984,52(3):263-266.
  • 10[13]STOCKER KF.Medical Use of Snake Venom Proteins[M].Florida:Boca Raton,1990:148.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部